"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,AU,A,AU 1999/031898 A,091-644-462-174-086,1999-10-11,1999,AU 1999/031898 A,1999-03-18,US 7835798 P;;US 9905867 W,1998-03-18,Gene therapy vector with osteocalcin promoter and genes for bone morphogenic proteins or growth factors,,UNIV VIRGINIA PATENT FOUNDATION,HELM GREGORY A;;HANKINS GERALD R;;ALDEN TORD D;;CHUNG LELAND W K;;KO SONG-CHU;;KAO CHINGHAI,,https://lens.org/091-644-462-174-086,Patent Application,no,0,0,2,2,0,A61K38/00;;A61K48/00;;C07K14/78;;C07K14/51;;C12N2799/022,A61K38/00;;A61K48/00;;C07K14/51;;C07K14/78;;C12N15/83,,0,0,,,,DISCONTINUED
2,WO,A1,WO 1999/047177 A1,014-177-039-290-685,1999-09-23,1999,US 9905867 W,1999-03-18,US 7835798 P,1998-03-18,GENE THERAPY VECTOR WITH OSTEOCALCIN PROMOTER AND GENES FOR BONE MORPHOGENIC PROTEINS OR GROWTH FACTORS,"The present invention relates to novel compositions containing nucleotide sequences which can be used as therapeutic agents for curing a wide variety of bone and spinal disorders. More specifically, the present invention relates to novel viral vectors which are used to deliver bone growth factor genes which induce endochondral bone formation to numerous tissues. The expression of the bone growth factor genes is regulated by tissue specific and/or inducible promoters. The present invention further relates to novel methods for using the therapeutic compositions. Specifically, the methods of the invention involve administering a bone growth factor gene, either directly or systemically, to a site where bone repair and/or regeneration is necessary.",UNIV VIRGINIA,HELM GREGORY A;;HANKINS GERALD R;;ALDEN TORD D;;CHUNG LELAND W K;;KO SONG-CHU;;KAO CHINGHAI,,https://lens.org/014-177-039-290-685,Patent Application,yes,0,6,2,2,0,A61K38/00;;A61K48/00;;C07K14/78;;C07K14/51;;C12N2799/022,A61K38/00;;A61K48/00;;C07K14/51;;C07K14/78;;C12N15/83,,4,3,072-217-283-816-738;;026-705-243-116-918;;018-643-826-309-788,9333121;;10.1359/jbmr.1997.12.10.1606;;9408606;;10.1074/jbc.274.11.6972;;10066751,"HANADA K., DENNIS J.E., CAPLAN A.I.: ""STIMULATORY EFFECTS OF BASIC FIBROBLAST GROWTH FACTOR AND BONE MORPHOGENETIC PROTEIN-2 ON OSTEOGENIC DIFFERENTIATION OF RAT BONE MARROW-DERIVED MESENCHYMAL STEM CELLS."", JOURNAL OF BONE AND MINERAL RESEARCH, BLACKWELL SCIENCE, INC., US, vol. 12., no. 10., 1 January 1997 (1997-01-01), US, pages 1606 - 1614., XP002919088, ISSN: 0884-0431, DOI: 10.1359/jbmr.1997.12.10.1606;;CHEON J., ET AL.: ""CHEMOGENE THERAPY: OSTEOCALCIN PROMOTER-BASED SUICIDE GENE THERAPY IN COMBINATION WITH METHOTREXATE IN A MURINE OSTEOSARCOMA MODEL."", CANCER GENE THERAPY, APPLETON & LANGE, GB, vol. 04., no. 06., 1 January 1997 (1997-01-01), GB, pages 359 - 365., XP002919089, ISSN: 0929-1903;;HARADA H., ET AL.: ""CBFA1 ISOFORMS EXERT FUNCTIONAL DIFFERENCES IN OSTEOBLAST DIFFERENTIATION."", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 274., no. 11., 1 January 1999 (1999-01-01), US, pages 6972 - 6978., XP002919090, ISSN: 0021-9258, DOI: 10.1074/jbc.274.11.6972;;ALDEN T.D., ET AL.: ""PERCUTANEOUS SPINAL FUSION USING BONE MORPHOGENETIC PROTEIN-2 GENE THERAPY."", JOURNAL OF NEUROSURGERY, AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS, US, vol. 90., 1 January 1999 (1999-01-01), US, pages 109 - 114., XP002919091, ISSN: 0022-3085",PENDING
